Use of toll-like receptor 2 (tlr-2) agonist for modulating human immune response
US-2025325659-A1 · Oct 23, 2025 · US
This page is not indexed by search engines while we improve data quality.
Levy Ofer patents
Levy Ofer is listed as an inventor on 30 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Levy Ofer |
| Total patents | 30 |
| First publication | Jun 4, 2015 |
| Latest publication | Oct 23, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response
US-12268739-B2 · Apr 8, 2025 · US
Tlr8 agonist for modulating immune response
US-2025041278-A1 · Feb 6, 2025 · US
Tlr4 agonist for modulating immune response
US-2025000971-A1 · Jan 2, 2025 · US
Polysaccharide adjuvants for virus vaccines
US-2024148864-A1 · May 9, 2024 · US
Sars-cov-2 antigen nanoparticles and uses there of
US-2024115693-A1 · Apr 11, 2024 · US
Tlr7/8 agonists to enhance immune responses in opioid using individuals
US-2023310438-A1 · Oct 5, 2023 · US
Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response
US-11730810-B2 · Aug 22, 2023 · US
Adjuvants for severe acute respiratory syndrome-related coronavirus (sars-cov) vaccines
US-2023201340-A1 · Jun 29, 2023 · US
Use of thiazole amide compounds for modulating human immune response
US-2023201339-A1 · Jun 29, 2023 · US
Recent patents
Latest publications not already listed above.
Imidazopyrimidine compounds and uses thereof
US-11673891-B2 · Jun 13, 2023 · US
Use of toll-like receptor 2 (tlr-2) agonist for modulating human immune response
US-2023132397-A9 · Apr 27, 2023 · US
Stimulator of Interferon Genes (STING) ligands and uses thereof
US-11633473-B2 · Apr 25, 2023 · US
Methods and compositions relating to adjuvants
US-11464854-B2 · Oct 11, 2022 · US
Novel imidazopyrimidine compounds and uses thereof
US-2022242867-A1 · Aug 4, 2022 · US
Use of toll-like receptor 2 (tlr-2) agonist for modulating human immune response
US-2022118085-A9 · Apr 21, 2022 · US
Stimulator of interferon genes (sting) ligands and uses thereof
US-2021299250-A1 · Sep 30, 2021 · US
Use of toll-like receptor 2 (tlr-2) agonist for modulating human immune response
US-2021236632-A1 · Aug 5, 2021 · US
Vaccine adjuvant compositions
US-10881729-B2 · Jan 5, 2021 · US
Use of imidazopyrimidine for modulating human immune response
US-2020282048-A1 · Sep 10, 2020 · US
Methods of evaluating immunogenicity of an agent using an artificial tissue construct
US-10731129-B2 · Aug 4, 2020 · US
Methods and compositions relating to adjuvants
US-2020108139-A1 · Apr 9, 2020 · US
BPI and its congeners as radiation mitigators and radiation protectors
US-9884089-B2 · Feb 6, 2018 · US
Bpi and its congeners as radiation mitigators and radiation protectors
US-2017354712-A9 · Dec 14, 2017 · US
BPI and its congeners as radiation mitigators and radiation protectors
US-9770484-B2 · Sep 26, 2017 · US
BPI and its congeners as radiation mitigators and radiation protectors
US-9770483-B2 · Sep 26, 2017 · US
Vaccine adjuvant compositions
US-2017224811-A1 · Aug 10, 2017 · US
Bpi and its congeners as radiation mitigators and radiation protectors
US-2017065676-A1 · Mar 9, 2017 · US
Bpi and its congeners as radiation mitigators and radiation protectors
US-2017056471-A1 · Mar 2, 2017 · US
Tissue constructs and uses thereof
US-2015152385-A1 · Jun 4, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Childrens Medical Center | 21 |
| Dana Farber Cancer Inst Inc | 16 |
| Children'S Medical Center Corp | 6 |
| Univ Of Montana | 2 |
| Childrens Medical Ct Corp | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K45/06 | 19 |
| A61K39/39 | 17 |
| A61K2039/55505 | 15 |
| A61K2039/55511 | 14 |
| A61K39/12 | 13 |